Innovative Antibody Discovery Workflow Leveraging Machine Learning

Innovative Antibody Discovery Workflow Leveraging Machine Learning to Prioritize Leads

We now offer an innovative end-to-end antibody screening solution that guides your discovery program to more diverse leads while reducing liabilities for antibody development.

The GENEWIZ precision antibody discovery (PAD) workflow increases the success of antibody screening as compared to traditional methods by:

• Uncovering 5-10x more antibody leads
• Increasing library diversity with 5-50x more clusters, including rare clones
• Focusing research efforts on the most commercially successful leads through reduced sequence liabilities